D

DIADEM DX

3 employees

Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.

Basic info

Industry

biotechnology research

Sectors

Therapeutics
ALZHEIMER'S

Date founded

2012

Funding rounds raised

Total raised

$11M

from 2 investors over 2 rounds

D

DIADEM DX raised $11M on March 28, 2022

Investors: PANAKES

D

DIADEM DX raised $8.2M on March 7, 2022

Investors: European Investment Bank

FAQ